Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

Richard W. Griffiths, Eyad Elkord, David E. Gilham, Vijay Ramani, Noel Clarke, Peter L. Stern, Robert E. Hawkins

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

Background: Regulatory T cells are important in maintaining immune homeostasis, mediating peripheral tolerance and preventing autoimmunity. Increased frequencies of CD4+CD25high T regulatory (T Reg) cells have been documented in the peripheral blood of patients with several types of cancer consistent with a role in tumour escape from immunological control. We have investigated the presence of TReg cells systemically and in situ in previously untreated patients with renal cell carcinoma (RCC). Results: We have shown that there is a significant increased frequency of CD4+CD25high T cells in RCC patients (n = 49) compared to normal donors (n = 38), respectively, 2.47% versus 1.50%; P < 0.0001. We confirmed these data using the FOXP3 marker of TReg cells in a subset of these patients and normal donors. The population of T Reg cells identified showed the expected phenotype with CD4 +CD25high population in both RCC patients and normal donors contained higher proportions of CD45RO and GITR than CD4 +CD25-/low populations and exhibiting suppressive activity in an anti-CD3 and anti-CD28 induced proliferation assay. CD4 +FOXP3+ T cells were detected in the tumour microenvironment by immunofluorescence and the numbers enumerated in lymphocytes recovered following enzymatic disaggregations of biopsies; their frequency was higher in the tumour than the peripheral blood of the same patients. The early follow up data show an association between higher peripheral blood regulatory T-cell count and adverse overall survival. Conclusion: These data confirm the increase of TReg cells in RCC patients and provide impetus to further investigate modulation of TReg activity in RCC patients as part of therapy.

Original languageEnglish
Pages (from-to)1743-1753
Number of pages11
JournalCancer Immunology, Immunotherapy
Volume56
Issue number11
DOIs
Publication statusPublished - Nov 2007
Externally publishedYes

Fingerprint

Regulatory T-Lymphocytes
Renal Cell Carcinoma
Survival
Tissue Donors
Tumor Escape
Population
Peripheral Tolerance
T-Lymphocytes
Tumor Microenvironment
Autoimmunity
Fluorescent Antibody Technique
Neoplasms
Homeostasis
Cell Count
Lymphocytes
Phenotype
Biopsy

Keywords

  • Renal cell carcinoma
  • Survival
  • T regulatory cells

ASJC Scopus subject areas

  • Cancer Research
  • Immunology
  • Oncology

Cite this

Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival. / Griffiths, Richard W.; Elkord, Eyad; Gilham, David E.; Ramani, Vijay; Clarke, Noel; Stern, Peter L.; Hawkins, Robert E.

In: Cancer Immunology, Immunotherapy, Vol. 56, No. 11, 11.2007, p. 1743-1753.

Research output: Contribution to journalArticle

Griffiths, Richard W. ; Elkord, Eyad ; Gilham, David E. ; Ramani, Vijay ; Clarke, Noel ; Stern, Peter L. ; Hawkins, Robert E. / Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival. In: Cancer Immunology, Immunotherapy. 2007 ; Vol. 56, No. 11. pp. 1743-1753.
@article{94e8d36dfb9942fd8467b22ea5a50d5c,
title = "Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival",
abstract = "Background: Regulatory T cells are important in maintaining immune homeostasis, mediating peripheral tolerance and preventing autoimmunity. Increased frequencies of CD4+CD25high T regulatory (T Reg) cells have been documented in the peripheral blood of patients with several types of cancer consistent with a role in tumour escape from immunological control. We have investigated the presence of TReg cells systemically and in situ in previously untreated patients with renal cell carcinoma (RCC). Results: We have shown that there is a significant increased frequency of CD4+CD25high T cells in RCC patients (n = 49) compared to normal donors (n = 38), respectively, 2.47{\%} versus 1.50{\%}; P < 0.0001. We confirmed these data using the FOXP3 marker of TReg cells in a subset of these patients and normal donors. The population of T Reg cells identified showed the expected phenotype with CD4 +CD25high population in both RCC patients and normal donors contained higher proportions of CD45RO and GITR than CD4 +CD25-/low populations and exhibiting suppressive activity in an anti-CD3 and anti-CD28 induced proliferation assay. CD4 +FOXP3+ T cells were detected in the tumour microenvironment by immunofluorescence and the numbers enumerated in lymphocytes recovered following enzymatic disaggregations of biopsies; their frequency was higher in the tumour than the peripheral blood of the same patients. The early follow up data show an association between higher peripheral blood regulatory T-cell count and adverse overall survival. Conclusion: These data confirm the increase of TReg cells in RCC patients and provide impetus to further investigate modulation of TReg activity in RCC patients as part of therapy.",
keywords = "Renal cell carcinoma, Survival, T regulatory cells",
author = "Griffiths, {Richard W.} and Eyad Elkord and Gilham, {David E.} and Vijay Ramani and Noel Clarke and Stern, {Peter L.} and Hawkins, {Robert E.}",
year = "2007",
month = "11",
doi = "10.1007/s00262-007-0318-z",
language = "English",
volume = "56",
pages = "1743--1753",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "11",

}

TY - JOUR

T1 - Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

AU - Griffiths, Richard W.

AU - Elkord, Eyad

AU - Gilham, David E.

AU - Ramani, Vijay

AU - Clarke, Noel

AU - Stern, Peter L.

AU - Hawkins, Robert E.

PY - 2007/11

Y1 - 2007/11

N2 - Background: Regulatory T cells are important in maintaining immune homeostasis, mediating peripheral tolerance and preventing autoimmunity. Increased frequencies of CD4+CD25high T regulatory (T Reg) cells have been documented in the peripheral blood of patients with several types of cancer consistent with a role in tumour escape from immunological control. We have investigated the presence of TReg cells systemically and in situ in previously untreated patients with renal cell carcinoma (RCC). Results: We have shown that there is a significant increased frequency of CD4+CD25high T cells in RCC patients (n = 49) compared to normal donors (n = 38), respectively, 2.47% versus 1.50%; P < 0.0001. We confirmed these data using the FOXP3 marker of TReg cells in a subset of these patients and normal donors. The population of T Reg cells identified showed the expected phenotype with CD4 +CD25high population in both RCC patients and normal donors contained higher proportions of CD45RO and GITR than CD4 +CD25-/low populations and exhibiting suppressive activity in an anti-CD3 and anti-CD28 induced proliferation assay. CD4 +FOXP3+ T cells were detected in the tumour microenvironment by immunofluorescence and the numbers enumerated in lymphocytes recovered following enzymatic disaggregations of biopsies; their frequency was higher in the tumour than the peripheral blood of the same patients. The early follow up data show an association between higher peripheral blood regulatory T-cell count and adverse overall survival. Conclusion: These data confirm the increase of TReg cells in RCC patients and provide impetus to further investigate modulation of TReg activity in RCC patients as part of therapy.

AB - Background: Regulatory T cells are important in maintaining immune homeostasis, mediating peripheral tolerance and preventing autoimmunity. Increased frequencies of CD4+CD25high T regulatory (T Reg) cells have been documented in the peripheral blood of patients with several types of cancer consistent with a role in tumour escape from immunological control. We have investigated the presence of TReg cells systemically and in situ in previously untreated patients with renal cell carcinoma (RCC). Results: We have shown that there is a significant increased frequency of CD4+CD25high T cells in RCC patients (n = 49) compared to normal donors (n = 38), respectively, 2.47% versus 1.50%; P < 0.0001. We confirmed these data using the FOXP3 marker of TReg cells in a subset of these patients and normal donors. The population of T Reg cells identified showed the expected phenotype with CD4 +CD25high population in both RCC patients and normal donors contained higher proportions of CD45RO and GITR than CD4 +CD25-/low populations and exhibiting suppressive activity in an anti-CD3 and anti-CD28 induced proliferation assay. CD4 +FOXP3+ T cells were detected in the tumour microenvironment by immunofluorescence and the numbers enumerated in lymphocytes recovered following enzymatic disaggregations of biopsies; their frequency was higher in the tumour than the peripheral blood of the same patients. The early follow up data show an association between higher peripheral blood regulatory T-cell count and adverse overall survival. Conclusion: These data confirm the increase of TReg cells in RCC patients and provide impetus to further investigate modulation of TReg activity in RCC patients as part of therapy.

KW - Renal cell carcinoma

KW - Survival

KW - T regulatory cells

UR - http://www.scopus.com/inward/record.url?scp=34548162594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548162594&partnerID=8YFLogxK

U2 - 10.1007/s00262-007-0318-z

DO - 10.1007/s00262-007-0318-z

M3 - Article

C2 - 17487490

AN - SCOPUS:34548162594

VL - 56

SP - 1743

EP - 1753

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 11

ER -